Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
|||||||
GSE180075 |
Type I interferon limits ILC2 effector functions through suppression of the CCR8-CCL1/CCL8 axis
|
10 | David Langlais | Jan 15, 2025 | ||||
GSE266052 |
Cytokine Priming Enhances the Antifibrotic Effects of Mesenchymal Stromal Cells Conditioned Medium Via Fibrogenic Myofibroblasts Elimination and Extracellular Matrix Degradation.
|
20 | David Langlais | Oct 15, 2024 | ||||
GSE249342 |
CCDC88B interacts with RASAL3 and ARHGEF2 to regulate dendritic cell function in neuroinflammation and colitis
|
2 | David Langlais | Jan 17, 2024 | ||||
GSE221454 |
Thermoneutrality and severe malaria: investigating the effect of warmer environmental temperatures on the inflammatory response and disease progression
|
17 | David Langlais | May 24, 2023 | ||||
GSE216486 |
Human IRF1 governs phagocytic IFN-γ immunity to mycobacteria but not cell-intrinsic IFN-a/b immunity to viruses [scRNAseq]
|
2 | David Langlais | Jan 12, 2023 | ||||
GSE216488 |
Human IRF1 governs phagocytic IFN-γ immunity to mycobacteria but not cell-intrinsic IFN-a/b immunity to viruses [CITEseq]
|
10 | David Langlais | Jan 12, 2023 | ||||
GSE216489 |
Human IRF1 governs phagocytic IFN-γ immunity to mycobacteria but not cell-intrinsic IFN-a/b immunity to viruses
|
12 | David Langlais | Jan 12, 2023 | ||||
GSE200222 |
Leishmania parasites exchange drug-resistance genes through extracellular vesicles
|
6 | David Langlais | Jul 19, 2022 | ||||
GSE176055 |
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study
|
17 | David Langlais | Apr 05, 2022 | ||||
GSE189385 |
The Role of Leishmania GP63 in Modulation of Innate Inflammatory Response to Leishmania major Infection
|
12 | David Langlais | Jan 01, 2022 | ||||
GSE167185 |
Inherited human c-REL deficiency disrupts adaptive immunity
|
11 | David Langlais | Aug 31, 2021 | ||||
GSE150663 |
MYSM1 maintains ribosomal protein gene expression in hematopoietic stem cells to prevent hematopoietic dysfunction I.
|
8 | David Langlais | Jul 28, 2020 | ||||
GSE150666 |
MYSM1 maintains ribosomal protein gene expression in hematopoietic stem cells to prevent hematopoietic dysfunction II.
|
24 | David Langlais | Jul 28, 2020 | ||||
GSE150667 |
MYSM1
|
61 | David Langlais | Jul 24, 2020 | ||||
GSE150665 |
Repression of p53-target gene Bbc3/puma by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance
|
29 | David Langlais | Jul 22, 2020 | ||||
GSE142069 |
ZBTB7B (ThPOK) IS REQUIRED FOR PATHOGENESIS OF CEREBRAL MALARIA AND PROTECTION AGAINST PULMONARY TUBERCULOSIS
|
2 | David Langlais | Dec 17, 2019 | ||||
GSE79702 |
USP15 regulates type I interferon response in vivo and is required for pathogenesis of microbial and autoimmune neuroinflammation
|
25 | David Langlais | Oct 10, 2016 | ||||
GSE77884 |
The macrophage IRF8-IRF1 regulome is required for protection against infections, and is associated with chronic inflammation (ChIP-Seq)
|
17 | David Langlais | Mar 07, 2016 | ||||
GSE77885 |
The macrophage IRF8-IRF1 regulome is required for protection against infections, and is associated with chronic inflammation (RNA-Seq)
|
12 | David Langlais | Mar 07, 2016 | ||||
GSE77886 |
The macrophage IRF8-IRF1 regulome is required for protection against infections, and is associated with chronic inflammation
|
29 | David Langlais | Mar 03, 2016 |